Vivian H. Liu - Feb 8, 2023 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Director
Signature
/s/ Joshua Disbrow as attorney-in-fact for Vivian H. Liu
Stock symbol
AYTU
Transactions as of
Feb 8, 2023
Transactions value $
$0
Form type
4
Date filed
2/10/2023, 05:13 PM
Previous filing
Jul 1, 2022
Next filing
Nov 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Shares Award $0 +6.5K +2000% $0.00 6.83K Feb 8, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share grant. One-third of the restricted shares shall vest on July 1, 2023; the remaining restricted shares shall vest quarterly thereafter, at 1/8th of the remaining grant, with full vesting on July 1, 2025.
F2 Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023.